Fred van Leuven
Corporate Officer/Principal at Katholieke Universiteit Leuven
Fred van Leuven active positions
| Companies | Position | Start | End |
|---|---|---|---|
| Katholieke Universiteit Leuven | Corporate Officer/Principal | - | - |
Career history of Fred van Leuven
Former positions of Fred van Leuven
| Companies | Position | Start | End |
|---|---|---|---|
| AC IMMUNE SA | Founder | 13/02/2003 | - |
reMYND NV
 reMYND NV Miscellaneous Commercial ServicesCommercial Services reMYND NV engages in the development of disease-modifying treatments against alzheimer's, parkinson's, diabetes and other protein misfolding disorders. Its drug and development unit focuses on innovative, disease-modifying drugs for treating degenerative disorders. The company was founded by Fred Van Leuven, Stefaan Wera and Joris Winderickx in 2002 and is headquartered in Leuven, Belgium. | Founder | 01/01/2002 | - |
Training of Fred van Leuven
| Ghent University | Graduate Degree |
Statistics
International
| Belgium | 4 |
| Switzerland | 2 |
Operational
| Founder | 2 |
| Graduate Degree | 1 |
| Corporate Officer/Principal | 1 |
Sectoral
| Consumer Services | 3 |
| Commercial Services | 2 |
| Health Technology | 2 |
Positions held
Active
Inactive
Listed companies
Private companies
Linked companies
| Listed companies | 1 |
|---|---|
| AC IMMUNE SA | Health Technology |
| Private companies | 1 |
|---|---|
reMYND NV
reMYND NV Miscellaneous Commercial ServicesCommercial Services reMYND NV engages in the development of disease-modifying treatments against alzheimer's, parkinson's, diabetes and other protein misfolding disorders. Its drug and development unit focuses on innovative, disease-modifying drugs for treating degenerative disorders. The company was founded by Fred Van Leuven, Stefaan Wera and Joris Winderickx in 2002 and is headquartered in Leuven, Belgium. | Commercial Services |
- Stock Market
- Insiders
- Fred van Leuven
- Experience
